PCH
Polar Capital Holdings’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.4M | Sell |
1,352,175
-225,000
| -14% | -$3.89M | 0.12% | 131 |
|
|
2025
Q1 | $34.5M | Hold |
1,577,175
| – | – | 0.21% | 116 |
|
|
2024
Q4 | $50.3M | Buy |
1,577,175
+495,175
| +46% | +$15.8M | 0.28% | 91 |
|
|
2024
Q3 | $31.2M | Buy |
1,082,000
+2,560
| +0.2% | +$73.8K | 0.15% | 115 |
|
|
2024
Q2 | $41.4M | Buy |
1,079,440
+25,000
| +2% | +$959K | 0.24% | 90 |
|
|
2024
Q1 | $62M | Buy |
1,054,440
+1,000
| +0.1% | +$58.8K | 0.33% | 75 |
|
|
2023
Q4 | $63.1M | Sell |
1,053,440
-435
| -0% | -$26K | 0.39% | 72 |
|
|
2023
Q3 | $40.1M | Buy |
1,053,875
+588,875
| +127% | +$22.4M | 0.3% | 87 |
|
|
2023
Q2 | $42.4M | Hold |
465,000
| – | – | 0.21% | 93 |
|
|
2023
Q1 | $30.7M | Buy |
465,000
+458,100
| +6,639% | +$30.2M | 0.2% | 112 |
|
|
2022
Q4 | $357K | Hold |
6,900
| – | – | ﹤0.01% | 300 |
|
|
2022
Q3 | $471 | Hold |
6,900
| – | – | ﹤0.01% | 342 |
|
|
2022
Q2 | $312 | Buy |
+6,900
| New | +$312 | ﹤0.01% | 370 |
|